Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-90,650
Closed -$14.9M 1
2017
Q1
$14.9M Hold
90,650
1.99% 9
2016
Q4
$13.3M Hold
90,650
1.87% 9
2016
Q3
$15.1M Buy
90,650
+6,000
+7% +$1.01M 2.07% 8
2016
Q2
$12.9M Hold
84,650
1.98% 8
2016
Q1
$12.7M Sell
84,650
-4,000
-5% -$594K 2.09% 7
2015
Q4
$14.4M Buy
88,650
+1,000
+1% +$157K 2.41% 6
2015
Q3
$12.1M Buy
87,650
+10,000
+13% +$1.58M 2.24% 6
2015
Q2
$11.9M Hold
77,650
2.13% 7
2015
Q1
$12.4M Hold
77,650
2.14% 7
2014
Q4
$12.4M Buy
77,650
+3,100
+4% +$483K 1.94% 7
2014
Q3
$10.5M Hold
74,550
1.99% 6
2014
Q2
$8.82M Hold
74,550
1.79% 6
2014
Q1
$9.2M Hold
74,550
1.85% 6
2013
Q4
$8.51M Buy
+74,550
New +$8.48M 1.71% 6

Other funds holding AMGN

LJ Trust's AMGN Position: Q2 2017 in Review

LJ Trust sold out of Amgen (AMGN) in Q2 2017, closing a stake of 90,650 shares — an estimated $14.9M sold.

LJ Trust first reported a position in AMGN in Q4 2013 and held it in 14 quarters. The position peaked at $15.1M in Q3 2016. 1,596 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • LJ Trust reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
  • LJ Trust sold 90,650 Amgen shares in Q2 2017, an estimated $14.9M.
  • LJ Trust first reported a position in Amgen in Q4 2013 and held it in 14 quarters.
  • LJ Trust's Amgen position peaked at $15.1M in Q3 2016.
  • 1,596 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on LJ Trust's 13F filing for Q2 2017.